Conference item : Abstract
Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 428.9KB, Terms of use)
-
- Publisher copy:
- 10.1089/hum.2016.29027.abstracts
Authors
- Publisher:
- Mary Ann Liebert
- Host title:
- Human Gene Therapy
- Journal:
- Human Gene Therapy More from this journal
- Publication date:
- 2016-06-15
- Acceptance date:
- 2019-04-15
- DOI:
- ISSN:
-
1557-7422, 1043-0342
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
pubs:719822
- UUID:
-
uuid:169cc579-c5b6-4a6d-9dee-594b92b52d2e
- Local pid:
-
pubs:719822
- Source identifiers:
-
719822
- Deposit date:
-
2019-06-18
- ARK identifier:
Terms of use
- Copyright holder:
- Mary Ann Liebert, Inc
- Copyright date:
- 2016
- Notes:
- © Mary Ann Liebert, Inc. This item is the abstract for a paper presented at the British Society for Gene and Cell Therapy Annual Conference 2016 (BSGCT 2016), London, UK, April 2016. This is the accepted manuscript version of the abstract. The final version is available online from Mary Ann Liebert, Inc. at: https://doi.org/10.1089/hum.2016.29027.abstracts
If you are the owner of this record, you can report an update to it here: Report update to this record